SCHEMBL21808985

SCHEMBL21808985

O=C1c2ccccc2C(=O)c2c1oc(-c1ccccc1)c2C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 10/20 0.68
ALDH1A1 P00352 10/20 0.68
MAPT P10636 9/20 0.68
APAF1 O14727 6/20 0.68
KMT2A Q03164 5/20 0.68
RAB9A P51151 4/20 0.68
L3MBTL1 Q9Y468 3/20 0.68
LMNA P02545 9/20 0.55
MITF O75030 2/20 0.55
SMN1; SMN2 Q16637 8/20 0.52
NPC1 O15118 5/20 0.52
NPSR1 Q6W5P4 4/20 0.52
TDP1 Q9NUW8 3/20 0.52
KDM4E B2RXH2 3/20 0.45
MEN1 O00255 4/20 0.44
CASP3 P42574 3/20 0.44
SENP8 Q96LD8 3/20 0.44
SENP7 Q9BQF6 3/20 0.44
SENP6 Q9GZR1 3/20 0.44
HPGD P15428 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16997940 0.90 HTT (0.59) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL29892254 0.81 HTT (1.00) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL21808931 0.81 HTT (1.00) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL2808423 0.78 NR4A2 (0.55) HTTALDH1A1MAPTKMT2ARAB9A
SCHEMBL21808989 0.78 HTT (0.68) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL16998411 0.78 HTT (0.68) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL21809001 0.77 HTT (0.67) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL16998405 0.77 HTT (0.80) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL23232542 0.75 USP1 (0.46) HTTALDH1A1MAPTAPAF1KMT2A
SCHEMBL27883703 0.74 MAPT (0.50) HTTALDH1A1MAPTAPAF1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919886-B2 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases ACADEMIA SINICA (TW) 2024-03-05 US disclosed
US-20230010562-A1 4,9-DIOXO-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-3-CARBOXAMIDE DERIVATIVES AND USES THEREOF FOR TREATING PROLIFERATIVE DISEASES AND INFECTIOUS DISEASES ACADEMIA SINICA (TW) 2023-01-12 US disclosed
US-11434229-B2 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases ACADEMIA SINICA (TW) 2022-09-06 US disclosed
US-20200095233-A1 4,9-DIOXO-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-3-CARBOXAMIDE DERIVATIVES AND USES THEREOF FOR TREATING PROLIFERATIVE DISEASES AND INFECTIOUS DISEASES ACADEMIA SINICA (TW) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230010562-A1 4,9-DIOXO-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-3-CARBOXAMIDE DERIVATIVES AND USES THEREOF FOR TREATING PROLIFERATIVE DISEASES AND INFECTIOUS DISEASES DHODH, NQO2, PKD1 HTT 3767/4885ALDH1A1 199/4885MAPT 4228/4885
US-20200095233-A1 4,9-DIOXO-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-3-CARBOXAMIDE DERIVATIVES AND USES THEREOF FOR TREATING PROLIFERATIVE DISEASES AND INFECTIOUS DISEASES DHODH, NQO2, PKD1 HTT 3767/4885ALDH1A1 199/4885MAPT 4228/4885
US-11434229-B2 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases DHODH, NQO2, PKD1 HTT 3767/4885ALDH1A1 199/4885MAPT 4228/4885
US-11919886-B2 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases DHODH, NQO2, PKD1 HTT 3767/4885ALDH1A1 199/4885MAPT 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.